“In October, Lexaria grew its portfolio of 19 international patent applications when it received patent allowance for DehydraTECH™ as a delivery platform for all cannabinoids , including (tetrahydrocannabinol) THC, fat soluble vitamins, non-steroidal anti-inflammatory pain medications (“NSAIDs”) and … Read More
The post NetworkNewsWire Announces Publication on M&A Action in the Cannabis Industry appeared first on Dagga Magazine.